 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
& o. l3 }" I @+ \1 L
" j# I9 ` t) r3 zEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX." B' E. O+ K1 D- Z( f- C1 u7 ^* z
, v% Z% Z+ p+ [3 \
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
/ T7 v- g) ~8 c; L9 m' A+ f$ {+ z ' @1 J$ Z* s. z, X d
. ~% m9 v8 g% y8 |8 Z
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.' _: I% F" Y: R \: U4 r" ^
3 `$ ?# V. q6 |, M
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
( s' g/ v" j+ N) z( L# p
+ O$ T3 W# C% K. N# ~* eThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
3 N4 k, _+ E: w" Y
0 C8 g! {# T5 O% WIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
- o! ~8 S- T0 `% ?0 W
4 Y; z/ V4 `) @- V q6 m9 s+ f/ ^It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.+ _+ R. u, \' g2 p
: ^1 l/ [' _6 v"As a scientist, it's one of the highlights of my CAREER," Shan said.
. F: v% l% E% P- \7 n. h" X% g( q7 D! ^* F6 A5 {
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
( F8 ~6 j, k r/ A: |( _# T& C2 W0 P- _' G
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said. ~6 a- _6 r( [+ H0 S8 K, b5 c
- `) [1 d8 G9 ]3 z! sGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
' _! h# K# e! W; P3 x( g- i& r1 L* D" S: _
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.& u1 t+ `; r! x) I" d% h$ X
9 o0 \) T4 p3 u7 j. T
. m; Y( O) ~8 d
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|